article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.

article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?

BioTech 270
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Stacy regularly advises on how COVID innovations such as telehealth need to remain as permanent options to enhance patient care. Connect with her at [link].

BioTech 107
article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Jane Reed, Director of Life Sciences at Linguamatics, an IQVIA company Pharmaceutical developers have always prioritized drug safety. Archana Hegde, Senior Director, Integrated PV Solutions at IQVIA The evolution of artificial intelligence (AI) such as generative AI has just begun. Dave Latshaw, CEO at BioPhy 1.

article thumbnail

Bonus Features, HLTH Edition – October 11, 2023 – Announcements from Best Buy, General Catalyst, Google Cloud, Microsoft, Walgreens, and more

Healthcare IT Today

” Google Cloud released new capabilities in Vertex AI Search for healthcare and life sciences, highlighting Hackensack Meridian Health and Highmark Health in its announcement. Walgreens also announced plans to launch telehealth visits later this month, according to Healthcare Dive.

article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

Speaking of design, this Summit was indeed well-designed by spotlighting pragmatic representatives from these various stakeholder groups.

article thumbnail

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. Patient interaction is available through an easy-to-use, engaging patient app available in more than 40 countries and 80 languages.